inThought Research.

Answers to out plan, out maneuver, and out market.

The inThought team delivers forward-looking analyses to healthcare professionals as well as to institutional investors. Analyses include a proprietary methodology for quantifying probability of FDA approval as well as a forecasting revenue methodology for both approved and develop-mental drugs and medical devices. Both the probability of approval models and revenue models are being integrated into the Wolters Kluwer Adis R&D Insight™ (RDI) product.

Request a Free Trial

Sign up for a free trial subscription that includes access to research alerts, expert calls, regional implications, ask the expert, and access to the inThought Library.